Published in Clin Exp Immunol on November 19, 2010
The function of introns. Front Genet (2012) 1.42
Macrophage migration inhibitory factor (MIF): genetic evidence for participation in early onset and early stage rheumatoid arthritis. Cytokine (2013) 0.98
Introns: The Functional Benefits of Introns in Genomes. Genomics Inform (2015) 0.76
Effect of variation in ovine WFIKKN2 on growth traits appears to be gender-dependent. Sci Rep (2015) 0.75
Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res (1983) 124.30
Transcription of eukaryotic protein-coding genes. Annu Rev Genet (2000) 6.12
Macrophage migration inhibitory factor: a regulator of innate immunity. Nat Rev Immunol (2003) 5.85
Going the distance: a current view of enhancer action. Science (1998) 5.83
MIF is a pituitary-derived cytokine that potentiates lethal endotoxaemia. Nature (1993) 5.60
The macrophage is an important and previously unrecognized source of macrophage migration inhibitory factor. J Exp Med (1994) 5.55
MIF as a glucocorticoid-induced modulator of cytokine production. Nature (1995) 5.21
Transcription factor Sp1 is essential for early embryonic development but dispensable for cell growth and differentiation. Cell (1997) 3.17
Sp transcription factor family and its role in cancer. Eur J Cancer (2005) 2.95
Sp1: emerging roles--beyond constitutive activation of TATA-less housekeeping genes. Biochem Biophys Res Commun (2008) 2.68
HIF1alpha delays premature senescence through the activation of MIF. Genes Dev (2006) 2.37
Mithramycin inhibits SP1 binding and selectively inhibits transcriptional activity of the dihydrofolate reductase gene in vitro and in vivo. J Clin Invest (1991) 2.28
Macrophage migration inhibitory factor in rheumatoid arthritis: evidence of proinflammatory function and regulation by glucocorticoids. Arthritis Rheum (1999) 2.17
Macrophage migration inhibitory factor promotes innate immune responses by suppressing glucocorticoid-induced expression of mitogen-activated protein kinase phosphatase-1. Eur J Immunol (2005) 2.09
An essential role for macrophage migration inhibitory factor in the tuberculin delayed-type hypersensitivity reaction. J Exp Med (1996) 1.99
Macrophage migration inhibitory factor is involved in the pathogenesis of collagen type II-induced arthritis in mice. J Immunol (1997) 1.86
Mithramycin blocks protein binding and function of the SV40 early promoter. J Clin Invest (1989) 1.53
Dual regulation of macrophage migration inhibitory factor (MIF) expression in hypoxia by CREB and HIF-1. Biochem Biophys Res Commun (2006) 1.47
The aureolic acid family of antitumor compounds: structure, mode of action, biosynthesis, and novel derivatives. Appl Microbiol Biotechnol (2006) 1.39
Involvement of macrophage migration inhibitory factor in the evolution of rat adjuvant arthritis. Arthritis Rheum (1998) 1.39
Macrophage migration inhibitory factor up-regulates expression of matrix metalloproteinases in synovial fibroblasts of rheumatoid arthritis. J Biol Chem (2000) 1.38
Nuclear receptor-mediated transactivation through interaction with Sp proteins. Prog Nucleic Acid Res Mol Biol (2004) 1.34
Mithramycin selectively inhibits transcription of G-C containing DNA. Am J Med Sci (1987) 1.31
Role of macrophage migration inhibitory factor (MIF) in murine antigen-induced arthritis: interaction with glucocorticoids. Clin Exp Immunol (2001) 1.29
Inhibition of c-src transcription by mithramycin: structure-activity relationships of biosynthetically produced mithramycin analogues using the c-src promoter as target. Biochemistry (2003) 1.27
Regulation of p53 by macrophage migration inhibitory factor in inflammatory arthritis. Arthritis Rheum (2003) 1.24
Sp1 is up-regulated in cellular and transgenic models of Huntington disease, and its reduction is neuroprotective. J Biol Chem (2006) 1.21
Macrophage migration inhibitory factor: a mediator of matrix metalloproteinase-2 production in rheumatoid arthritis. Arthritis Res Ther (2006) 1.19
Novel GC-rich DNA-binding compound produced by a genetically engineered mutant of the mithramycin producer Streptomyces argillaceus exhibits improved transcriptional repressor activity: implications for cancer therapy. Nucleic Acids Res (2006) 1.19
Hypoxia-induced activation of the retinoic acid receptor-related orphan receptor alpha4 gene by an interaction between hypoxia-inducible factor-1 and Sp1. J Biol Chem (2004) 1.16
Use of gene expression profiling to identify a novel glucocorticoid sensitivity determining gene, BMPRII. FASEB J (2006) 1.15
Preliminary observations on the therapy of the myeloid blast phase of chronic granulocytic leukemia with plicamycin and hydroxyurea. N Engl J Med (1986) 1.08
Reduced arthritis in MIF deficient mice is associated with reduced T cell activation: down-regulation of ERK MAP kinase phosphorylation. Clin Exp Immunol (2008) 1.05
High expression of macrophage migration inhibitory factor in the synovial tissues of rheumatoid joints. Cytokine (1999) 1.03
SP1 and SP3 mediate progesterone-dependent induction of the 17beta hydroxysteroid dehydrogenase type 2 gene in human endometrium. Biol Reprod (2006) 0.99
Regulation of constitutive and microbial pathogen-induced human macrophage migration inhibitory factor (MIF) gene expression. Eur J Immunol (2007) 0.98
Human macrophage migration inhibitory factor: a proven immunomodulatory cytokine? J Biol Chem (2006) 0.96
Identification of macrophage migration inhibitory factor in murine neonatal calvariae and osteoblasts. Immunology (1996) 0.94
Transcriptional activation of the macrophage migration-inhibitory factor gene by the corticotropin-releasing factor is mediated by the cyclic adenosine 3',5'- monophosphate responsive element-binding protein CREB in pituitary cells. Mol Endocrinol (1998) 0.93
Macrophage migration inhibitory factor and glucocorticoid sensitivity. Rheumatology (Oxford) (2006) 0.92
A pilot study of alpha-interferon and plicamycin for accelerated phase of chronic myeloid leukemia. Leuk Res (1997) 0.91
Transgenic mice overexpressing macrophage migration inhibitory factor (MIF) exhibit high-turnover osteoporosis. J Bone Miner Res (2006) 0.90
Glucocorticoids suppress macrophage migration inhibitory factor (MIF) expression in a cell-type-specific manner. J Mol Endocrinol (2005) 0.87
Novel transcriptional regulation of the human CYP3A7 gene by Sp1 and Sp3 through nuclear factor kappa B-like element. J Biol Chem (2001) 0.84
Hypoxia and glucocorticoid signaling converge to regulate macrophage migration inhibitory factor gene expression. Arthritis Rheum (2009) 0.84
Mithramycin downregulates proinflammatory cytokine-induced matrix metalloproteinase gene expression in articular chondrocytes. Arthritis Res Ther (2005) 0.84
Active immunization against macrophage migration inhibitory factor using a novel DNA vaccine prevents ovariectomy-induced bone loss in mice. Vaccine (2007) 0.79
Mithramycin A activates Fas death pathway in leukemic cell lines. Apoptosis (2006) 0.78
Effect of mithramycin on bone beta-glucuronidase and resorption. Calcif Tissue Res (1978) 0.78
Commitment, choice and self-control. J Exp Anal Behav (1972) 16.93
A gene map of the human genome. Science (1996) 14.32
EFFECT OF HYDROGEN-ION CONCENTRATION ON CHLORELLA PHOTOSYNTHESIS. Plant Physiol (1938) 12.77
A physical map of 30,000 human genes. Science (1998) 12.43
Area under the curve as a measure of discounting. J Exp Anal Behav (2001) 6.48
Discounting of delayed rewards: Models of individual choice. J Exp Anal Behav (1995) 5.53
Recombination in Escherichia coli and the definition of biological species. J Bacteriol (1991) 5.37
Distribution and abundance of insertion sequences among natural isolates of Escherichia coli. Genetics (1987) 4.77
Tobacco use by youth: a surveillance report from the Global Youth Tobacco Survey project. Bull World Health Organ (2000) 4.65
Choice between rewards differing in amount and delay: Toward a choice model of self control. J Exp Anal Behav (1980) 3.20
Cancer mortality in workers exposed to phenoxy herbicides, chlorophenols, and dioxins. An expanded and updated international cohort study. Am J Epidemiol (1997) 3.10
Translation initiation in Escherichia coli: sequences within the ribosome-binding site. Mol Microbiol (1992) 3.10
Plasma oxytocin levels in autistic children. Biol Psychiatry (1998) 2.77
Diagnosis and antibiotic treatment of acute otitis media: report from International Primary Care Network. BMJ (1990) 2.77
Control of recA gene RNA in E. coli: regulatory and signal genes. Cell (1980) 2.51
Establishment and maintenance of repression by bacteriophage lambda: the role of the cI, cII, and c3 proteins. Proc Natl Acad Sci U S A (1971) 2.35
Preventing medication errors in cancer chemotherapy. Am J Health Syst Pharm (1996) 2.33
Abnormal hypothalamic-pituitary-adrenal axis function in rheumatoid arthritis. Effects of nonsteroidal antiinflammatory drugs and water immersion. Arthritis Rheum (1994) 2.30
Degradation of intracellular protein in Salmonella typhimurium peptidase mutants. J Mol Biol (1980) 2.28
Lactic acidosis in patients with diabetes treated with metformin. N Engl J Med (1998) 2.26
Macrophage migration inhibitory factor in rheumatoid arthritis: evidence of proinflammatory function and regulation by glucocorticoids. Arthritis Rheum (1999) 2.17
Serious adverse events in Norplant users reported to the Food and Drug Administration's MedWatch Spontaneous Reporting System. Obstet Gynecol (1995) 2.12
Acute otitis media in adults: a report from the International Primary Care Network. J Am Board Fam Pract (1993) 2.07
RELATION BETWEEN QUANTITY OF CHLOROPHYLL AND CAPACITY FOR PHOTOSYNTHESIS. Plant Physiol (1940) 2.02
Lapse, relapse and survival among opiate addicts after treatment. A prospective follow-up study. Br J Psychiatry (1989) 1.98
Teenagers' knowledge of emergency contraception: questionnaire survey in south east Scotland. BMJ (1996) 1.93
Transposable element IS50 improves growth rate of E. coli cells without transposition. Cell (1983) 1.91
Distribution of DNA insertion element IS5 in natural isolates of Escherichia coli. Proc Natl Acad Sci U S A (1984) 1.91
Matching and maximizing with concurrent ratio-interval schedules. J Exp Anal Behav (1983) 1.83
A better way to keep in touch with patients. Med Econ (1996) 1.81
Pigeons' preferences for stimulus information: effects of amount of information. J Exp Anal Behav (1977) 1.72
Peptide accumulation during growth of peptidase deficient mutants. J Mol Biol (1980) 1.72
Response of the hypothalamic-pituitary-adrenal axis to psychological stress in patients with psoriasis. Br J Dermatol (2005) 1.67
Empiric use of vancomycin during prolonged treatment-induced granulocytopenia. Randomized, double-blind, placebo-controlled clinical trial in patients with acute leukemia. Am J Med (1986) 1.64
The physical maps for sequencing human chromosomes 1, 6, 9, 10, 13, 20 and X. Nature (2001) 1.63
HIV multidisciplinary teams work: support services improve access to and retention in HIV primary care. AIDS Care (2002) 1.63
Antibiotic treatment influences outcome in murine sepsis: mediators of increased morbidity. Shock (1998) 1.62
Economic and biological influences on a pigeon's key peck. J Exp Anal Behav (1975) 1.60
Building momentum: an ethnographic study of inner-city redevelopment. Am J Public Health (1999) 1.60
A major human histone gene cluster on the long arm of chromosome 1. Science (1984) 1.59
Role of the cro gene in bacteriophage lambda development. J Mol Biol (1973) 1.58
Oligopeptidase-deficient mutants of Salmonella typhimurium. J Bacteriol (1983) 1.57
Pulmonary dirofilariasis: the great imitator of primary or metastatic lung tumor. A clinicopathologic analysis of seven cases and a review of the literature. Hum Pathol (1989) 1.57
Computerized transaxial tomography in the evaluation of patients with focal epilepsy. Neurology (1975) 1.57
Resistance to mercury and to cadmium in chromosomally resistant Staphylococcus aureus. Antimicrob Agents Chemother (1986) 1.56
Endogenous sensory neuropeptide release enhances nonspecific airway responsiveness in guinea pigs. Am Rev Respir Dis (1992) 1.55
The relation between estrogen receptors and response rate to cytotoxic chemotherapy in metastatic breast cancer. N Engl J Med (1978) 1.54
Adverse reaction reporting of interaction between warfarin and fluoroquinolones. Arch Intern Med (1991) 1.53
Does intravenous methadone provide longer lasting analgesia than intravenous morphine? A randomized, double-blind study. Pain (1989) 1.53
Detection of Escherichia coli ribosome binding at translation initiation sites in the absence of tRNA. J Mol Biol (1991) 1.52
Positive and negative regulation by the cII and cIII gene products of bacteriophage lambda. Virology (1975) 1.49
Retinal changes mimicking diabetic retinopathy in two nondiabetic, growth hormone-treated patients. J Clin Endocrinol Metab (1998) 1.47
Comparison of three culture media for isolation of Mycobacterium tuberculosis: a 6-year study. Appl Microbiol (1973) 1.45
Cellular basis of potato spindle tuber viroid systemic movement. Virology (2001) 1.43
Sentinel practices. 1982. Fam Med (2000) 1.42
Conference report: community-based health promotion--state of the art and recommendations for the future. Am J Prev Med (1997) 1.41
Juvenile idiopathic arthritis classified by the ILAR criteria: HLA associations in UK patients. Rheumatology (Oxford) (2002) 1.39
Fatal syndrome in lambs. Vet Rec (1994) 1.39
Involvement of macrophage migration inhibitory factor in the evolution of rat adjuvant arthritis. Arthritis Rheum (1998) 1.39
Treatment of entropion in lambs. Vet Rec (1991) 1.39
Churg-Strauss syndrome: the use of cyclophosphamide in mononeuritis. Rheumatology (Oxford) (2003) 1.38
Does the NIH statement fill the bill on hip replacement? Am Fam Physician (1995) 1.37
Opiate withdrawal: inpatient versus outpatient programmes and preferred versus random assignment to treatment. Br Med J (Clin Res Ed) (1986) 1.36
Soft tissue sarcoma and non-Hodgkin's lymphoma in workers exposed to phenoxy herbicides, chlorophenols, and dioxins: two nested case-control studies. Epidemiology (1995) 1.36
Distribution, frequency, and quantitative analysis of estrogen, progesterone, androgen, and glucocorticoid receptors in human breast cancer. Cancer Res (1979) 1.35
The evolution of DNA sequences in Escherichia coli. Philos Trans R Soc Lond B Biol Sci (1986) 1.35
Pregnancy and cystic fibrosis. Obstet Gynecol (1991) 1.33
Exposure to dioxin and nonneoplastic mortality in the expanded IARC international cohort study of phenoxy herbicide and chlorophenol production workers and sprayers. Environ Health Perspect (1998) 1.32
Distribution of type X collagen mRNA in normal and osteoarthritic human cartilage. Bone Miner (1991) 1.31
Consumption-leisure tradeoffs in pigeons: Effects of changing marginal wage rates by varying amount of reinforcement. J Exp Anal Behav (1987) 1.30
Role of macrophage migration inhibitory factor (MIF) in murine antigen-induced arthritis: interaction with glucocorticoids. Clin Exp Immunol (2001) 1.29
Gastric emptying in early noninsulin-dependent diabetes mellitus. J Nucl Med (1996) 1.28
Association between steroid hormone receptor status and disease-free interval in breast cancer. Cancer Treat Rep (1979) 1.27
Regulation of synoviocyte phospholipase A2 and cyclooxygenase 2 by macrophage migration inhibitory factor. Arthritis Rheum (2001) 1.25
NATURE OF THE BLACKMAN REACTION IN PHOTOSYNTHESIS. Plant Physiol (1937) 1.24
On the nature of cis-acting regulatory proteins and genetic organization in bacteriophage: the example of gene Q of bacteriophage lambda. Genetics (1976) 1.23
Behavioral economics (Editorial). J Exp Anal Behav (1995) 1.21
Circadian timing in the lung; a specific role for bronchiolar epithelial cells. Endocrinology (2008) 1.21
Macrophage migration inhibitory factor (MIF) gene polymorphism is associated with susceptibility to but not severity of inflammatory polyarthritis. Genes Immun (2003) 1.18
Signalling, cycling and desensitisation of gonadotrophin-releasing hormone receptors. J Endocrinol (2002) 1.17
Regulation of macrophage migration inhibitory factor by endogenous glucocorticoids in rat adjuvant-induced arthritis. Arthritis Rheum (2000) 1.15
Gamma-irradiated Venezuelan equine encephalitis vaccines. Appl Microbiol (1970) 1.15
Some properties of site-specific and general recombination inferred from int-initiated exchanges by bacteriophage lambda. Genetics (1979) 1.14
Empowering communities: action research through healthy cities. Health Educ Q (1994) 1.13
Inhibitory effect of annexin I on synovial inflammation in rat adjuvant arthritis. Arthritis Rheum (1999) 1.13
Cell cycle regulation of human histone H1 mRNA. Proc Natl Acad Sci U S A (1984) 1.09
Specific deletion occurring in the directed evolution of 6-phosphogluconate dehydrogenase in Escherichia coli. Genetics (1984) 1.09
Families as full research partners: what's in it for us? J Behav Health Serv Res (1999) 1.08
Arthritis in psoriasis. Ann Rheum Dis (1981) 1.08
Ovarian Leydig cell tumor in a peri-menopausal woman with severe hyperandrogenism and virilization. Gynecol Endocrinol (2005) 1.08
Hypothalamic-pituitary-adrenal function and glucocorticoid sensitivity in atopic dermatitis. Pediatrics (2000) 1.08
Mutational analyses of BRCA1 and BRCA2 in Ashkenazi and non-Ashkenazi Jewish women with familial breast and ovarian cancer. Hum Mutat (2000) 1.07
Characterization of an in vitro-selected RNA ligand to the HIV-1 Rev protein. J Mol Biol (1994) 1.06
Reduced arthritis in MIF deficient mice is associated with reduced T cell activation: down-regulation of ERK MAP kinase phosphorylation. Clin Exp Immunol (2008) 1.05
Is there a decisive test between matching and maximizing? J Exp Anal Behav (1988) 1.05
Antiinflammatory effect of lipocortin 1 in experimental arthritis. Inflammation (1997) 1.05
Impaired processing of proopiomelanocortin in corticotroph macroadenomas. J Clin Endocrinol Metab (1996) 1.05
Chemical exposure in manufacture of phenoxy herbicides and chlorophenols and in spraying of phenoxy herbicides. Am J Ind Med (1993) 1.04